| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |